Article Text

Download PDFPDF
EP1074 Prevalence of high risk human papillomavirus infection among Iranian women using COBAS HPV DNA testing
  1. F Farzaneh1,
  2. F Jamdar1,
  3. F Navidpour2,
  4. S Yunesi3,
  5. P Balvayeh4,
  6. M Hosseini1 and
  7. R Robabeh Ghodssi-Ghasemabadi5
  1. 1Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran
  2. 2Manager of Post Analytical Quality Control Department in Nilou Lab, Theran
  3. 3Technical Manager of Nilou Laboratory
  4. 4Anatomical and Clinical Pathologist, Nilou Laboratory
  5. 5Department of Biostatistics, Faculty of Medical Sciences, Tarbiat-Modares University, Tehran, Islamic Republic of Iran


Introduction/Background Persistent infection with High Risk Human Papillomavirus (HR HPV) types plays a major role in the development of cervical cancer. Therefore, the detection of HR HPV types is an essential part of cervical cancer screening. The aim of this study was to estimate the prevalence of HR HPV infection among healthy women undergoing routine cervical cancer screening in Iran.

Methodology In this cross-sectional study, 2453 normal Iranian women who were referred for routine cervical cancer screening from September 2015 to March 2017 were recruited. Participants were screened using COBAS assay for HPV DNA typing and liquid based cytology. The results of HPV DNA typing and Cytology were analyzed.

Results A total of 2453 healthy sexually active women were included in this study. The mean age was 35.1±8. 08 years. The overall prevalence of HR HPV infection was 10.3%. HPV16 was found in 73 (3%) women. The prevalence of HPV18 and other HR HPV typeswere 16(0.7%) and166 (8.2%),respectively. Approximately, 5% of the study population had an abnormal cervical cytology (ASCUS or worse), of whom 34% were infected by HR HPV.

Conclusion The prevalence of HR HPV infection among Iranian women has increased in the recent years which indicates the need for public education and health planning to prevent this cancer through vaccination and early diagnosis using screening tests.HPV DNA typing, diagnosis and the distribution of prevalent genotypes should be considered in the development of comprehensive cervical cancer prevention programs in Iran

Disclosure Nothing to disclose

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.